GL1X · GenesisL1 explorer

MolNFT v1 · #189483 · protein

Crystal structure of EP300 hat domain in complex with compound 7

7VHZ · Histone acetyltransferase P300: “Crystal structure of EP300 hat domain in complex with compound 7”. X-ray diffraction, 2 ligands (6TI, ZN), 14 pockets (best druggability 0.81). MolNFT v1 #189483 on GenesisL1: 3D structure, binding…

PDB
7VHZ
Type
protein
Length
878 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase P300
EC
2.3.1.48
UniProt
Q09472
Ligands
6TI, ZN
Pockets
14 · best druggability 0.81

Structure

x-ray diffraction · 2 distinct chains · 34% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase P300 (EC 2.3.1.48)protein44134% helix, 23% strandQ09472
BHistone acetyltransferase P300 (EC 2.3.1.48)protein43734% helix, 22% strandQ09472

Ligands and binding sites

  • 6TI · (2R)-N-(2H-indazol-4-yl)-1-[1-(4-methoxyphenyl)cyclopentyl]carbonyl-pyrrolidine-2-carboxamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 6 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110870.810.8379empty
24120.720.83466TI
34670.700.80546TI
42570.620.8034empty
52190.580.8034empty

Interfaces

1 interface between chains.

  • A–B · 572 Ų buried · 10 hydrogen bonds · protein-protein

Compared structures

  • 7VHZ · Crystal structure of EP300 HAT domain in complex with compound 7 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q09472 · AlphaFold monomer V2.0 prediction for histone acetyltransferase P300 (Q09472) · a predicted model of the same protein · chain B against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.